Form 4 for ZVRA ZEVRA THERAPEUTICS, INC.
Accepted 2023-05-18 00:00:00 ET · period of report 2023-05-18 · accession 0001437749-23-015140 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| M | 2023-05-18 | 2023-05-18 | ZVRA | Clifton R. LaDuane | CFO, Sec, Treas | P - Purchase | $4.95 | +2,740 | 13.7K | +25% | +$13.6K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2023-05-18 | P | A | 2,000 | $4.95 | 13,053 | D | — | — | |
| 2 | Common | Common Stock | 2023-05-18 | P | A | 51 | $4.94 | 11,053 | D | — | — | |
| 3 | Common | Common Stock | 2023-05-18 | P | A | 689 | $4.95 | 13,742 | D | — | — |